By Dr. Lisa Parker, DNP, APRN, NP — Owner & Clinical Director, Parker Neuroscience, Omaha, Nebraska

Why does ketamine seem to help some people dramatically while others don’t experience the same results?

Patients ask me this regularly, and it deserves an honest answer rather than a sales answer. So here it is: mental health treatment is rarely one-size-fits-all. Just as some patients respond well to one antidepressant while others don’t, ketamine therapy is not equally effective for every individual. We know from both research and clinical experience that many patients experience meaningful improvement in symptoms of depression, anxiety, or PTSD. Some experience partial improvement. And some experience little benefit at all.

A clinic that promises you dramatic results is telling you about its marketing. A clinic that explains why results vary is telling you about medicine. Let me do the second one.

Depression is not a single disease

The starting point for understanding variable response is this: depression is not a single disease with a single cause. Two patients with the same diagnosis on paper can be carrying entirely different underlying biology and history.

Genetics, brain chemistry, other medical conditions, trauma history, substance use, chronic stress, sleep quality, inflammation, and co-occurring mental health conditions can all influence how someone responds to treatment, any treatment, including ketamine. When response varies, it isn’t because the patient did something wrong or the medicine is a gamble. It’s because “depression” is a single word describing many different underlying situations.

This is exactly why treatment at Parker Neuroscience begins with a thorough evaluation rather than a protocol pulled off a shelf. Understanding your situation is not a formality before treatment. It is treatment.

Improvement doesn’t always arrive the way you expect

Timing plays a role too, and it surprises people in two directions.

Some patients experience dramatic improvement after a single treatment. But for many others, meaningful change happens gradually across a series of treatments, which is why a typical course is structured as a series rather than a single session. If you’re weighing what that series actually looks like day to day, our walk-through of a first appointment covers it step by step.

Just as important: improvement doesn’t always show up first where you’re looking for it. I’ve seen patients begin noticing better sleep, returning motivation, or steadier emotional resilience before they notice any change in mood itself. If you’re only watching your mood, you can miss the early evidence that treatment is working. This is one of the reasons we track symptoms carefully throughout treatment, more on that below.

What happens outside the treatment room matters

Ketamine may create an opportunity for change. But lasting improvement is usually strengthened by what surrounds the treatment: healthy lifestyle habits, psychotherapy, supportive relationships, and ongoing mental health care.

The analogy I use with my patients: ketamine may help open a door that has felt stuck for a very long time. But you still need to walk through the door and continue the work of healing on the other side. Patients who pair treatment with therapy and genuine life engagement tend to build the most durable change, the treatment creates the opening; what you do with the opening is where healing lives.

This is also why we actively coordinate with your therapists, primary care providers, and psychiatric team rather than treating in a silo. Interventional treatment works best integrated into a broader care plan, not bolted onto the side of one.

The good news: we don’t have to guess

Here is the part I most want you to hear if you’re weighing this decision: whether treatment is helping is not left to impressions.

Throughout your treatment series, we monitor symptoms carefully, track your progress, and continuously evaluate whether the treatment is working for you. If you’re responding, we’ll see it, sometimes before you feel it. If you’re not responding the way we’d hoped, we’ll see that too, and we’ll have an honest conversation about adjusting the plan or considering other options. You will not be left wondering, and you will not be sold indefinite treatment on hope alone.

Hope and realistic expectations, you need both

If you’re considering ketamine therapy, I’d encourage you to bring two things to the decision: hope, because for many patients this treatment offers genuine, meaningful relief after years of feeling stuck, and realistic expectations, because no honest clinician can promise you a specific outcome.

Our goal is always the same: identify the treatment plan that gives you the best opportunity for meaningful improvement and a better quality of life. For some patients that’s ketamine. For some it’s Spravato. For some, it’s a different path entirely, and we’ll tell you that, too.

If addiction risk is part of what’s making this decision feel heavy, I’ve answered that one directly as well: Is Ketamine Therapy Addictive?

Questions related to this one

What’s the realistic success rate? Research and clinical experience show that many patients with treatment-resistant depression experience meaningful improvement with ketamine-based treatment, while some see partial benefit and some see little. Your individual likelihood depends on your history and clinical picture, which is what the evaluation is designed to assess. For a deeper look at the published evidence, see our article on ketamine and Spravato remission rates.

How many treatments before I know if it’s working? It varies. Some patients notice change within the first sessions; others improve gradually across the induction series. Because we track your symptoms at every stage, you and Dr. Parker will be evaluating the evidence together rather than waiting for a feeling.

If ketamine doesn’t work for me, what then? Then we say so, and we talk about what’s next, adjusting the protocol where appropriate, considering Spravato, coordinating with your existing providers, or recommending a different direction entirely. A treatment that isn’t helping you is not a treatment we continue selling you.

Does being on other medications change my response? Your current medications are part of your intake evaluation, and some can be relevant to treatment planning. Bring a complete list to your consultation, it’s one of the factors we review before any treatment is offered.

If you are in crisis, call or text 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room.

This article is for informational purposes only and does not constitute medical advice or establish a patient-provider relationship. Ketamine and Spravato carry potential risks; individual candidacy is determined through clinical evaluation by Dr. Parker.

Parker Neuroscience, LLC · 179 Welch Plaza, Suite 106, Omaha, NE 68135 · (402) 915-1862